FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

377454002: Haemophilus b polysaccharide + tetanus toxoid 10mcg/24mcg (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    1202773012 Haemophilus b polysaccharide + tetanus toxoid 10mcg/24mcg (product) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT core
    1478812017 Haemophilus b polysaccharide+tetanus toxoid 10mcg/24mcg en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core
    4726861000005119 Haemophilus influenzae type B-polysaccharidvaccine 10 µg + tetanustoxoid 24 µg da Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) Danish module (core metadata concept)

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Haemophilus influenzae type B-polysaccharidvaccine 10 µg + tetanustoxoid 24 µg Is a Haemophilus influenzae type b-polysaccharidvaccine, konjugeret (difteritoxoidkonjugat) false Inferred relationship Some
    Haemophilus influenzae type B-polysaccharidvaccine 10 µg + tetanustoxoid 24 µg The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. vaccine mod influenzavirus false Inferred relationship Some
    Haemophilus influenzae type B-polysaccharidvaccine 10 µg + tetanustoxoid 24 µg The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. vaccine mod Haemophilus influenzae type B false Inferred relationship Some
    Haemophilus influenzae type B-polysaccharidvaccine 10 µg + tetanustoxoid 24 µg Is a Haemophilus influenzae type B- + tetanusvaccine false Inferred relationship Some
    Haemophilus influenzae type B-polysaccharidvaccine 10 µg + tetanustoxoid 24 µg The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. tetanustoxoid false Inferred relationship Some
    Haemophilus influenzae type B-polysaccharidvaccine 10 µg + tetanustoxoid 24 µg The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. tetanusvaccine false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group

    Reference Sets

    Concept inactivation indicator reference set

    Back to Start